Skip to search formSkip to main contentSkip to account menu

proxodolol

Known as: 3-methyl-5-(2-(3-(tert-butylamino)-2-hydroxypropoxy)phenoxymethyl)-1,2,4-oxadiazole 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A new form of ophthalmic preparations is proposed. A suspension of poly(N-isopropylacrylamide) (poly(NIPAA)) hydrogel is capable… 
2005
2005
Gas chromatography was used to study the pharmacokinetics of Proxodolol eye drops, a new Russian hybrid beta-alpha adrenergic… 
1994
1994
In non-inbred rats, the pharmacokinetics of proxodolol was studied after its intravenous administration in a dose of 1 mg/kg or… 
1994
1994
The clinical and instrumental investigations of 38 patients with mild and moderate arterial hypertension have shown that therapy… 
1994
1994
: The effects of placebo and proxodolol, a new hybrid (beta-, alpha-) adrenoblocking agent, on exercise tolerance, hemodynamics… 
1994
1994
: The antihypertensive efficacy and hemodynamic effects of the new hybrid (beta-, alpha-) adrenoceptor blocking agent proxodolol… 
1994
1994
The effect of the new hybrid (beta-, alpha-) adrenoceptor blocking drug proxodolol on cardiac output and its distribution between…